Literature DB >> 7438586

Enzymatic analysis and collagen content in endomyocardial biopsy samples of patients with congestive cardiomyopathy of unknown etiology.

H P Schultheiss, H D Bolte, S Fischer, J Cyran.   

Abstract

Endomyocardial biopsy samples from patients suffering from congestive cardiomyopathy of unknown etiology (COCM) were analyzed for lactate dehydrogenase (LDH) isoenzyme distribution by microisoelectric focusing. In addition, the concentration of collagen in the biopsy samples was estimated by determination of hydroxyproline and proline. The results were correlated with the clinical and hemodynamic data of the patients. Increased activities of total LDH and LDH5--the worse the hemodynamic parameters, the higher the concentration of LDH5--indicate an enhanced anaerobic glycolysis in the myocardium of COCM patients. The close correlation between the hemodynamic data and the LDH isoenzyme pattern suggests an association between severity of COCM and impairment of aerobic metabolism. The results of the alteration in the LDH isoenzyme pattern were not influenced by the collagen content in the myocardial biopsy samples. Varying isoenzyme patterns in the different parts and wall layers of the normal heart show the necessity of analyzing biopsy samples only from comparable localizations.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7438586     DOI: 10.1002/clc.4960030407

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  2 in total

1.  Coenzyme Q10 and key enzyme activities in papillary muscle related to left ventricle function in mitral valve disease.

Authors:  J Karlsson; C Sylvén; E Jansson; K Böök; K Muratsu; K Folkers
Journal:  Mol Cell Biochem       Date:  1988-11       Impact factor: 3.396

2.  Micromethods for determining activities of energy-producing and non-energy-producing pathways in myocardial tissue.

Authors:  J W King; F S Kennedy; H G Hanley; J J Lierl; M R Fowler; M C White
Journal:  Am J Pathol       Date:  1986-05       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.